Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/05/053055
CTRI/2023/05/053055
Not yet recruiting
未知

A prospective pilot study to assess the effect of Resveratrol-Copper on the viral load in patients with Chronic Hepatitis B and C virus infection

Tata Memorial Hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: B191- Unspecified viral hepatitis B

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B191- Unspecified viral hepatitis B
Sponsor
Tata Memorial Hospital
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age above 18 years
  • •\-ECOG\- performance status of 0 or 1
  • •\-Chronic HBV infection with HBV DNA levels more than equal to 2000 IU per mL and normal ALT alanine amino transferase
  • •These patients are not routinely treated with antivirals due to limited activity. ALT is traditionally considered to be marker of hepatocellular injury. Various studies using interferon, peg interferon, Lamivudine, Adefovir have shown the importance of elevated ALT levels in predicting the response rate to therapy
  • •\-Chronic HCV infection with detectable HCV RNA levels and Genotype 2 or \-who are eligible for antiviral treatment as per standard guidelines
  • •\-No active malignancy at least 1 year of DFS following successful anticancer Rx
  • •\-Adequate hepatic, renal, and hematologic function at baseline
  • •\-Patients who have given written informed consent

Exclusion Criteria

  • •\-Age more 60 years
  • •\-Any other Genotype of HCV
  • •\-Acute Hepatitis
  • •\-Cirrhosis
  • •\-Decompensated chronic liver disease
  • •\-Concurrent chemotherapy
  • •\-Current or previous antiviral treatment for HBV or HCV
  • •\-Coexistent dual infection\- i.e. HBV with HCV
  • •\-Coexistent HIV infection
  • •\-Uncontrolled medical comorbidities like hypertensive, diabetes mellitus

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
study to test the effect of music on quality of life of cancer patients undergoing chemotherapyHealth Condition 1: D499- Neoplasm of unspecified behavior of unspecified site
CTRI/2023/03/050509Apollo Proton Cancer Centre
Not yet recruiting
Not Applicable
A prospective pilot study evaluating the effects of a clinically-supervised weight loss intervention programme combined with behavioural change strategy in morbidly obese adults in SingaporeObesityPublic Health - Health service researchDiet and Nutrition - Obesity
ACTRN12612000163808Hanniel Han Rong LIM40
Active, not recruiting
Phase 1
A pilot study to assess the impact of genetic polymorphisms in the ABCB1 and ABCG2 genes on brain and organ penetration of dual Pgp/BCRP substrates in humans.The effect of genetic polymorphisms on drug distribution will be investigated in healthy volunteersTherapeutic area: Body processes [G] - Genetic Phenomena [G05]
EUCTR2012-005796-14-ATMedizinische Universität Wien60
Not yet recruiting
Not Applicable
Estimation of type of hearing loss using a new Forehead knuckle tapping method
CTRI/2021/01/030777Dr Prem Sagar
Active, not recruiting
Phase 1
Study to evaluate the efficacy of OnabotulinumtoxinA in migraine
EUCTR2017-002866-38-ITIRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO42